Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 7,900 shares, an increase of 43.6% from the May 31st total of 5,500 shares. Based on an average daily trading volume, of 1,100 shares, the short-interest ratio is currently 7.2 days.
Innate Pharma Price Performance
Innate Pharma stock remained flat at $2.49 during mid-day trading on Monday. The company’s 50 day moving average is $2.40 and its two-hundred day moving average is $2.60. Innate Pharma has a 1-year low of $2.13 and a 1-year high of $3.36.
About Innate Pharma
Recommended Stories
- Five stocks we like better than Innate Pharma
- Are Penny Stocks a Good Fit for Your Portfolio?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Calculate Return on Investment (ROI)
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Quiet Period Expirations Explained
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.